Results 1 to 10 of about 338,057 (225)

Preoperative Temporal Elevation of Cytokeratin 19 Fragment in Thymoma With Extensive Necrosis: A Case Report [PDF]

open access: yesThoracic Cancer
In a mediastinal tumor accompanied by inflammation and a low‐density area, cytokeratin 19 fragment (CYFRA) was elevated, but it decreased preoperatively. The pathological diagnosis was thymoma with extensive necrosis (possibly Type B). A temporal CYFRA elevation may indicate tumor necrosis. Thymoma with necrosis should be considered in the differential
Nishioka Y   +7 more
europepmc   +2 more sources

Advanced Thymoma and Advanced Thymic Carcinoma Treatment Practices in 2018–2022: A Nationwide Analysis in Japan [PDF]

open access: yesThoracic Cancer
Introduction Thymomas and thymic carcinomas are rare diseases with limited clinical evidence. This study aimed to investigate the clinical characteristics of and treatment practices for Stages III and IV thymoma or thymic carcinoma in Japan.
Junichi Ishigaki   +3 more
doaj   +2 more sources

Downregulation of HMGB1 in thymoma cells affects T cell differentiation

open access: yesCentral European Journal of Immunology, 2023
Introduction: Thymoma is the most common anterior mediastinal tumor and is closely associated with myasthenia gravis (MG). Our previous study showed that the expression of Th17 cells increased and the expression of Treg decreased in MG-associated thymoma
Jian Li   +5 more
doaj   +1 more source

Case Report: MDM4 Amplified in a Thymoma Patient With Autoimmune Enteropathy and Myocarditis

open access: yesFrontiers in Endocrinology, 2021
IntroductionThymoma is a type of mediastinal malignant tumors which always associated with autoimmune diseases. Although surgery is the predominant treatment method for thymoma, the pathogenesis of thymoma and thymoma-associated autoimmune diseases is ...
Xin Du   +6 more
doaj   +1 more source

YAP1-MAML2 Fusion as a Diagnostic Biomarker for Metaplastic Thymoma

open access: yesFrontiers in Oncology, 2021
BackgroundMetaplastic thymoma is a very rare tumor with only a few case reports documented in literature. Hence, its molecular features have not been well explored.Material and MethodsSeventeen specimens of metaplastic thymoma were sequenced and ...
Jikai Zhao   +5 more
doaj   +1 more source

Coexistence of Thymus and Colon Adenocarcinoma: A Case Report

open access: yesVan Tıp Dergisi, 2021
Thymoma is a very rare tumor with a rate of 1.7 per million. Thymoma often occurs between the ages of 35-70. Thymoma is frequently located in the anterior mediastinum. Patients with thymoma often do not cause symptoms clinically.
Muhammed Selim Bodur   +8 more
doaj   +1 more source

Identification of differentially expressed circular RNAs associated with thymoma

open access: yesThoracic Cancer, 2021
Background Thymomas and thymic carcinomas are the most common tumor types among anterior mediastinal lesions. However, the relationship between molecular aberrations and thymoma patients are poorly understood, especially abnormal changes in the ...
Qingjun Wu   +8 more
doaj   +1 more source

Expression and Diagnostic Value of NPTX1 in Thymoma Patients

open access: yesChinese Journal of Lung Cancer, 2021
Background and objective Thymomas are the most common primary malignant tumors of anterior mediastinal. However, there are no specific laboratory indicator for the diagnosis the diagnosis of thymoma. The aim of this study was to screen out a tumor marker
Xin DU   +4 more
doaj   +1 more source

MC-ViT: Multi-path cross-scale vision transformer for thymoma histopathology whole slide image typing

open access: yesFrontiers in Oncology, 2022
ObjectivesAccurate histological typing plays an important role in diagnosing thymoma or thymic carcinoma (TC) and predicting the corresponding prognosis.
Huaqi Zhang   +7 more
doaj   +1 more source

Analysis of Gene Variation in Thymoma by Microarray

open access: yesChinese Journal of Lung Cancer, 2020
Background and objective Thymoma is the most common malignant tumor in anterior mediastinum, and its specific pathogenesis is still unclear. This limits the study of targeted drugs for thymoma.
Lijun WANG, Lei YU, Xin DU, Chengyu HUO
doaj   +1 more source

Home - About - Disclaimer - Privacy